tailieunhanh - Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Despite its cardiotoxicity doxorubicin is widely used for the treatment of paediatric malignancies. Current treatment regimens appear to be suboptimal as treatment strategies vary and do not follow a clear pharmacological rationale. | Can we optimise doxorubicin treatment regimens for children with cancer Pharmacokinetic simulations and a Delphi consensus procedure

TỪ KHÓA LIÊN QUAN